Position in AZN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$337,523
-$13,528 QoQ
Shares Held
1,780
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#997
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Management Associates, Inc. holds $14,108,701 across 10 Drug Manufacturers - General names. AZN ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,266 | $3,369,166 | |
| 2 | LLY |
ELI LILLY & Co
|
2,744 | $3,291,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,581 | $2,002,158 | |
| 4 | ABBV |
AbbVie Inc.
|
6,759 | $1,700,834 | |
| 5 | PFE |
Pfizer Inc
|
63,133 | $1,520,242 | |
| 6 | AMGN |
Amgen Inc
|
3,099 | $1,122,209 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
1,780 | $337,523 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,535 | $320,271 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,523 | 1,780 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $351,051 | 1,780 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||